Skip to main content
. 2013 May;20(5):549–556. doi: 10.1177/1933719112459226

Table 1.

Characteristics of Study Cohort by Baseline Level of Urinary FSH (Low, Middle, and High; N = 209).a

Low (N = 59), <7 mIU/mg cr Middle (N = 108), 7-11.9 mIU/mg cr High (N = 42), ≥12 mIU/mg cr P Valueb
Age, years .002
 30-34 45 (76) 78 (72) 21 (50)
 35-37 9 (15) 19 (18) 9 (21)
 38-44 5 (9) 11 (10) 12 (29)
Body mass index, kg/m2 .50
 <18.5 2 (3) 3 (3) 1 (2)
 18.5-24 37 (64) 70 (65) 24 (58)
 25-29 11 (19) 24 (22) 8 (20)
 ≥30 8 (14) 11 (10) 8 (20)
History of gonorrhea or chlamydia 4 (7) 3 (3) 1 (2) .38
Current smoker 1 (2) 2 (2) 1 (2) .97
Hormonal contraceptivec use in past year 33 (57) 42 (39) 21 (50) .07
Menstrual cycle day of urine collection 3 (2-4) 3 (2-4) 3 (2-4) .80
Questionnaire: regular menstrual cycles 57 (97) 89 (83) 37 (88) .04
Diaryd: intercycle menstrual length variancee 7.0 (2.3-21.3) 4.5 (1.3-10.3) 4.3 (1.3-13.0) .24
Menstrual cycle length, days
 Questionnaire 28.0 (28.0-30.0) 28.5 (28.0-30.0) 28.0 (27.0-29.5) .29
 Diary datad 29.4 (27.0-32.6) 28.5 (27.0-31.4) 28.2 (26.3-31.5) .36

Abbreviations: cr, creatinine; FSH, follicle-stimulating hormone.

a Data presented as number (%) or median (interquartile range).

b For categorical variables, the Cochran-Mantel-Haenszel tests for association were used. For the continuous variables, the nonparametric Kruskal-Wallis test was employed. P values were not adjusted for other variables in the table.

c Oral contraceptive pills, contraceptive patch, or contraceptive vaginal ring.

d For women that have diary data (n = 174).

e For women with diary data for more than 1 cycle (N = 131).